中华肝脏病杂志
中華肝髒病雜誌
중화간장병잡지
CHINESE JOURNAL OF HEPATOLOGY
2008年
6期
449-452
,共4页
王蕾%赵玉峰%李亚丽%徐跃飞%夏泉%马克里
王蕾%趙玉峰%李亞麗%徐躍飛%夏泉%馬剋裏
왕뢰%조옥봉%리아려%서약비%하천%마극리
脂质筏,细胞膜%肝细胞生长因子受体%磷脂酶类%磷脂酰肌醇-3-激酶%有丝分裂原激活蛋白激酶
脂質筏,細胞膜%肝細胞生長因子受體%燐脂酶類%燐脂酰肌醇-3-激酶%有絲分裂原激活蛋白激酶
지질벌,세포막%간세포생장인자수체%린지매류%린지선기순-3-격매%유사분렬원격활단백격매
Lipid raft,cell membrane%Hepatocyte growth factor receptor%Phospholipases%Phosphatidylinositol 3-Kinase%Mitogen-activated protein kinases
目的 探讨脂筏在肝细胞生长因子受体介导的信号跨膜转导中的作用.方法 采用甲基-β-环糊精(MβCD)处理HepG2细胞,以干扰脂筏的形成,然后加入人工重组肝细胞生长因子以活化其受体.采用Western blot技术及计算机扫描定量分析分别检测MβCD处理组和对照组细胞磷脂酶Cγ1(PLCγ1)/二脂酰甘油/蛋白激酶C信号通路、磷脂酰肌醇-3-激酶/磷脂酰肌醇依赖的蛋白激酶/蛋白激酶B信号通路和有丝分裂原激活的蛋白激酶(MAPK)信号通路活性的变化.结果 (1)用MβCD处理细胞后,细胞PLCγ1磷酸化程度降低,为对照组的65%(P=0.022);胞浆中PLCγ1含量增加,为对照组的1.75倍(P=0.017);膜结合的PLCγ1减少,为对照组的70%(P=0.037).(2)用MβCD处理细胞后,胞浆中蛋白激酶B含量减少,为对照组的62%(P=0.028),同时膜结合的蛋白激酶B磷酸化程度降低,为对照组的86%(P=0.041).用MβCD处理细胞同时可抑制磷脂酰肌醇依赖的蛋白激酶由胞浆向质膜的转移及活化.(3)MβCD处理对MAPK信号通路,包括细胞外信号调节蛋白激酶/MAPK信号通路、p38/MAPK信号通路和C-Jun N末端蛋白激酶/MAPK信号通路均无显著的影响.结论 抑制脂筏形成可下调肝细胞生长因子/c-Met对PLCγ1/二脂酰甘油/蛋白激酶C信号通路和磷脂酰肌醇-3-激酶/磷脂酰肌醇依赖的蛋白激酶/蛋白激酶B信号通路的活化.
目的 探討脂筏在肝細胞生長因子受體介導的信號跨膜轉導中的作用.方法 採用甲基-β-環糊精(MβCD)處理HepG2細胞,以榦擾脂筏的形成,然後加入人工重組肝細胞生長因子以活化其受體.採用Western blot技術及計算機掃描定量分析分彆檢測MβCD處理組和對照組細胞燐脂酶Cγ1(PLCγ1)/二脂酰甘油/蛋白激酶C信號通路、燐脂酰肌醇-3-激酶/燐脂酰肌醇依賴的蛋白激酶/蛋白激酶B信號通路和有絲分裂原激活的蛋白激酶(MAPK)信號通路活性的變化.結果 (1)用MβCD處理細胞後,細胞PLCγ1燐痠化程度降低,為對照組的65%(P=0.022);胞漿中PLCγ1含量增加,為對照組的1.75倍(P=0.017);膜結閤的PLCγ1減少,為對照組的70%(P=0.037).(2)用MβCD處理細胞後,胞漿中蛋白激酶B含量減少,為對照組的62%(P=0.028),同時膜結閤的蛋白激酶B燐痠化程度降低,為對照組的86%(P=0.041).用MβCD處理細胞同時可抑製燐脂酰肌醇依賴的蛋白激酶由胞漿嚮質膜的轉移及活化.(3)MβCD處理對MAPK信號通路,包括細胞外信號調節蛋白激酶/MAPK信號通路、p38/MAPK信號通路和C-Jun N末耑蛋白激酶/MAPK信號通路均無顯著的影響.結論 抑製脂筏形成可下調肝細胞生長因子/c-Met對PLCγ1/二脂酰甘油/蛋白激酶C信號通路和燐脂酰肌醇-3-激酶/燐脂酰肌醇依賴的蛋白激酶/蛋白激酶B信號通路的活化.
목적 탐토지벌재간세포생장인자수체개도적신호과막전도중적작용.방법 채용갑기-β-배호정(MβCD)처리HepG2세포,이간우지벌적형성,연후가입인공중조간세포생장인자이활화기수체.채용Western blot기술급계산궤소묘정량분석분별검측MβCD처리조화대조조세포린지매Cγ1(PLCγ1)/이지선감유/단백격매C신호통로、린지선기순-3-격매/린지선기순의뢰적단백격매/단백격매B신호통로화유사분렬원격활적단백격매(MAPK)신호통로활성적변화.결과 (1)용MβCD처리세포후,세포PLCγ1린산화정도강저,위대조조적65%(P=0.022);포장중PLCγ1함량증가,위대조조적1.75배(P=0.017);막결합적PLCγ1감소,위대조조적70%(P=0.037).(2)용MβCD처리세포후,포장중단백격매B함량감소,위대조조적62%(P=0.028),동시막결합적단백격매B린산화정도강저,위대조조적86%(P=0.041).용MβCD처리세포동시가억제린지선기순의뢰적단백격매유포장향질막적전이급활화.(3)MβCD처리대MAPK신호통로,포괄세포외신호조절단백격매/MAPK신호통로、p38/MAPK신호통로화C-Jun N말단단백격매/MAPK신호통로균무현저적영향.결론 억제지벌형성가하조간세포생장인자/c-Met대PLCγ1/이지선감유/단백격매C신호통로화린지선기순-3-격매/린지선기순의뢰적단백격매/단백격매B신호통로적활화.
Objective To study the effects of lipid rafts on cell signal transmembrane transduction mediated by c-Met. Methods After HepG2Cells were treated with MβCD to disrupt the lipid rafts and were treated with artificial recombination hepatocyte growth factor to activate c-Met, the activities of PLCγ1/PKC, P13K/Akt and MAPK signaling pathways in HepG2 cells were analyzed using Western blot. Results (1) After disruption of lipid rafts with MβCD, phosphorylation of PLCγ1 decreased by 35% (P=0.022); the content of PLCγ in the cytoplasm increased by 1.75 fold (P=0.017); PLCγ1 conjugated with membrane decreased by 30% (P=0.037). (2) The content of PKB in the cytosol decreased by 38% (P=0.028), and the phosphorylation level of PKB conjugated with membrane decreased by 14% (P=0.041). At the same time, PDK translocation from cytosol to the plasma membrane and its activation were inhibited by treatment with MβCD. (3) Treatment with MβCD had no significant effect on ErK/MAPK, p38/MAPK and JNK/MAPK signaling pathways. Conclusion Disruption of lipid rafts with MβCD inhibits the activation of PLCγ1/PKC and PI3K/PKB signaling pathways by HGF/cMet, but has no effect on MAPK signaling pathway.